Estrella Immunopharma ESLA
NASDAQ ESLA
$0.79 +0.05 (+6.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Estrella Immunopharma (ESLA) Other Accumulated Expenses (2021 - 2026)

Updated

Estrella Immunopharma (ESLA) recorded Other Accumulated Expenses of $1,059 in Q2 2026, down 33.3% from the prior quarter.

Analysis

Estrella Immunopharma (ESLA) Other Accumulated Expenses (2021 - 2026) Analysis & Trends

At the end of FY2025, Estrella Immunopharma reported Other Accumulated Expenses of $18,751, up 76.4% from FY2024.

  • Across earlier years, Other Accumulated Expenses came in at $10,631 in FY2024 and $398,781 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Estrella Immunopharma 32.66 Mn 27.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,059.00
Mar 31, 2026 1,587.00
Dec 31, 2025 18,751.00
Sep 30, 2025 4,000.00
Jun 30, 2025 4,000.00
Mar 31, 2025 3,200.00
Dec 31, 2024 10,631.00
Sep 30, 2024 2,825.00
Jun 30, 2024 347.00
Mar 31, 2024 391.00
Dec 31, 2023 2,558.00
Sep 30, 2023 5.07 Mn
Jun 30, 2023 398,781.00
Mar 31, 2023 13,100.00
Dec 31, 2022 144,127.00
Sep 30, 2022 30,658.00
Jun 30, 2022 48,200.00
Mar 31, 2022 24,200.00
Dec 31, 2021 70,154.00
Sep 30, 2021 97,600.00
API Access

Estrella Immunopharma Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ESLA&period=max&api_key=YOUR_API_KEY